News
Important Only
Other
Evolv Technology Appoints Chris Kutsor As Chief Financial Officer
April 23 (Reuters) - Evolv Technologies Holdings Inc EVLV.O:EVOLV TECHNOLOGY APPOINTS CHRIS KUTSOR AS CHIEF FINANCIAL OFFICEREVOLV TECHNOLOGIES HOLDINGS INC - KUTSOR'S APPOINTMENT EFFECTIVE AFTER 2024 ANNUAL REPORT FILINGReuters
Wed, Apr 23
Other
LG Electronics delays India unit IPO on market jitters, source says
By Aditya Kalra and Heekyong Yang NEW DELHI/SEOUL, April 23 (Reuters) - South Korea's LG Electronics 066570.KS has delayed its Indian unit's LGEL.NS IPO plans due to market volatility and is now targeting launching the offering in the second or third quarter of fiscal year 2025-2026, inst...Reuters
Wed, Apr 23
Other
Amentum Announces Agreement To Divest Its Rapid Solutions Product Business For $360 Million
April 23 (Reuters) - Amentum Holdings Inc AMTM.N:AMENTUM ANNOUNCES AGREEMENT TO DIVEST ITS RAPID SOLUTIONS PRODUCT BUSINESS FOR $360 MILLIONAMENTUM HOLDINGS INC - TO SELL RAPID SOLUTIONS TO LOCKHEED MARTIN FOR $360 MILLIONAMENTUM HOLDINGS INC - 230 EMPLOYEES TO TRANSITION TO LOCKHEED MARTINAMENTUM H...Reuters
Wed, Apr 23
Other
Serbia's NIS oil company seeks third sanctions waiver from US
BELGRADE, April 23 (Reuters) - Serbian oil company NIS NIIS.BEL, majority-owned by Russian Gazprom Neft SIBN.MM and Gazprom GAZP.MM, has asked the U.S. for a third waiver from sanctions which could cut its crude supply, it said on Wednesday.NIS operates a single oil refinery in Serbia with annual ca...Reuters
Wed, Apr 23
Economic Indicator
Street View: Capital One's strong earnings show resilient consumer spending
** Capital One Financial COF.N reported a rise in first-quarter profit on Tuesday, helped by a higher income from interest payments on its credit card debt** Shares of the consumer lender up 3.1% at $175.47 in premarket trading** Last week, U.S. banking regulators approved Capital One's $35.3 bl...Reuters
Wed, Apr 23
Stocks
Summit Therapeutics gains as lung cancer drug succeeds in second study in China
** Shares of Summit Therapeutics SMMT.O up 13.41% at $31.05 before the bell ** Company and partner Akeso's 9926.HK drug ivonescimab, in combination with chemotherapy, showed "statistically significant superiority" in progression-free survival for patients with a type of lung cancer ** Th...Reuters
Wed, Apr 23
Stocks
U.S. STOCKS ON THE MOVE-Oklo, AT&T, Philip Morris
Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures leapt on Wednesday after President Donald Trump pulled back on his threats to fire Federal Reserve Chair Jerome ...Reuters
Wed, Apr 23
Other
Rezolute Announces Pricing Of Offering Of $90 Million Of Common Stock And Pre-Funded Warrants
April 23 (Reuters) - Rezolute Inc RZLT.O:REZOLUTE ANNOUNCES PRICING OF OFFERING OF $90 MILLION OF COMMON STOCK AND PRE-FUNDED WARRANTSREZOLUTE INC - PRICES UNDERWRITTEN OFFERING OF 20.8 MILLION SHARES AT $3.25 EACHReuters
Wed, Apr 23
Other
National Bank Of Canada Announces Acquisition Of PGM Global Holdings Inc.
April 23 (Reuters) - National Bank of Canada NA.TO:NATIONAL BANK OF CANADA ANNOUNCES ACQUISITION OF PGM GLOBAL HOLDINGS INC.NATIONAL BANK OF CANADA - TRANSACTION VALUE NOT MATERIAL TO BANK'S FINANCIAL POSITIONReuters
Wed, Apr 23
Stocks
AT&T Surpasses Q1 Revenue Estimates
Telecommunications giant AT&T (NYSE:T) reported fiscal 2025 first quarter earnings on Wednesday, April 23, that matched or exceeded analysts' consensus expectations. Revenue of $30.63 billion came in ahead of the forecasted $30.36 billion and rose 2% year over year. Adjusted earnings per share (EPS)...The Motley Fool
Wed, Apr 23
Other
Phathom Pharmaceuticals To Report First Quarter 2025 Financial Results And Provide Business Update On Thursday, May 1, 2025
April 23 (Reuters) - Phathom Pharmaceuticals Inc PHAT.O:PHATHOM PHARMACEUTICALS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON THURSDAY, MAY 1, 2025Reuters
Wed, Apr 23
Stocks
Boston Scientific raises 2025 profit forecast on strong heart device sales
April 23 (Reuters) - Boston Scientific BSX.N raised its annual profit forecast after strong sales of its heart devices helped beat Wall Street expectations for first-quarter profit.Shares of the medical device maker soared nearly 10% in premarket trading, as the raised forecast alleviated investor c...Reuters
Wed, Apr 23
